New Key Statistics Module, Z-Score and F-Score
NAS:ACAD Key Ratios
| Market Cap $ M | 2,519.62 |
| Enterprise Value $ M | 2,108.74 |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | 23.47 |
| Price/Book | 5.42 |
| Price/Sales | 3.10 |
| Price/Free Cash Flow | 39.71 |
| Price/Owner Earnings | 1,386.36 |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | 813.00 |
| EPS (TTM) $ | -0.01 |
| Beneish M-Score | -2.44 |
| 10-y EBITDA Growth Rate % | 1.10 |
| 5-y EBITDA Growth Rate % | 22.30 |
| y-y EBITDA Growth Rate % | -- |
| EV-to-EBIT | -459.92 |
| EV-to-EBITDA | 347.46 |
| PEG | -- |
| Shares Outstanding M | 165.22 |
| Net Margin (%) | -0.21 |
| Operating Margin % | -0.56 |
| Pre-tax Margin (%) | 1.83 |
| Quick Ratio | 1.86 |
| Current Ratio | 2.04 |
| ROA % (ttm) | -0.24 |
| ROE % (ttm) | -0.42 |
| ROIC % (ttm) | 0.28 |
| Dividend Yield % | -- |
| Altman Z-Score | 1.41 |
ACAD Number of Guru Trades
ACAD Volume of Guru Trades
Gurus Latest Trades with NAS:ACAD
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:ACAD is held by these investors
Total 1
ACADIA Pharmaceuticals Inc Insider Transactions
No Available Data
News about NAS:ACAD
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers